For use as an adjunct to intramammary therapy in the treatment of acute bacterial mastitis with systemic involvement, caused by organisms sensitive to framycetin, in dairy cows. In vitro framycetin has shown activity against E. coli, Staphylococcus aureus, Actinomyces (C.) pyogenes and Klebsiella spp.